Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

XBX:GR

39.304 EUR 0.371 0.95%

As of 09:33:18 ET on 04/27/2015.

Snapshot for Cambrex Corp (XBX)

Open: 39.120 Day's Range: 39.120 - 39.304 Volume: 0
Previous Close: 38.933 52wk Range: 12.452 - 41.683 1-Yr Rtn: +164.41%

Stock Chart for XBX

No chart data available.
  • XBX:GR 39.304
  • 1D
  • 1M
  • 1Y
38.933
Interactive XBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XBX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 25.4717
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 1.6830
Est. PEG Ratio 1.6981
Market Cap (M EUR) 1,294.32
Shares Outstanding (M) 32.93
30 Day Average Volume 31
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 14.0000
Dividend Ex-Date 05/04/2007
5 Year Dividend Growth -
Next Earnings Announcement 05/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XBX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XBX

Cambrex Corp. supplies products, services, and technologies for the Life Sciences and fine chemicals industry. The Company builds platforms for use in manufacturing small molecule Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates including drug delivery. Cambrex's services include process & analytical development, scale-up in addition to generic APIs.

Steven M Klosk "Steve"President/CEOGregory P SargenExec VP/CFO
Shawn P CavanaghExec VP/COOSamantha M HanleyVP/Secretary/General Counsel
More Company Profile & Key Executives for XBX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil